Standard

Drivers and barriers of vaccine acceptance among pregnant women in Kenya. / Otieno, Nancy A; Otiato, Fredrick; Nyawanda, Bryan; Adero, Maxwel; Wairimu, Winnie N; Ouma, Dominic; Atito, Raphael; Wilson, Andrew; Gonzalez-Casanova, Ines; Malik, Fauzia A; Widdowson, Marc-Alain; Omer, Saad B; Chaves, Sandra S; Verani, Jennifer R.

In: Human Vaccines & Immunotherapeutics, 2020, blz. 1-9.

Onderzoeksoutput: Bijdrage aan tijdschriftA1: Web of Science-artikel

Harvard

Otieno, NA, Otiato, F, Nyawanda, B, Adero, M, Wairimu, WN, Ouma, D, Atito, R, Wilson, A, Gonzalez-Casanova, I, Malik, FA, Widdowson, M-A, Omer, SB, Chaves, SS & Verani, JR 2020, 'Drivers and barriers of vaccine acceptance among pregnant women in Kenya', Human Vaccines & Immunotherapeutics, blz. 1-9. https://doi.org/10.1080/21645515.2020.1723364

APA

Otieno, N. A., Otiato, F., Nyawanda, B., Adero, M., Wairimu, W. N., Ouma, D., ... Verani, J. R. (2020). Drivers and barriers of vaccine acceptance among pregnant women in Kenya. Human Vaccines & Immunotherapeutics, 1-9. https://doi.org/10.1080/21645515.2020.1723364

Vancouver

Otieno NA, Otiato F, Nyawanda B, Adero M, Wairimu WN, Ouma D et al. Drivers and barriers of vaccine acceptance among pregnant women in Kenya. Human Vaccines & Immunotherapeutics. 2020;1-9. https://doi.org/10.1080/21645515.2020.1723364

Author

Otieno, Nancy A ; Otiato, Fredrick ; Nyawanda, Bryan ; Adero, Maxwel ; Wairimu, Winnie N ; Ouma, Dominic ; Atito, Raphael ; Wilson, Andrew ; Gonzalez-Casanova, Ines ; Malik, Fauzia A ; Widdowson, Marc-Alain ; Omer, Saad B ; Chaves, Sandra S ; Verani, Jennifer R. / Drivers and barriers of vaccine acceptance among pregnant women in Kenya. In: Human Vaccines & Immunotherapeutics. 2020 ; blz. 1-9.

BibTeX

@article{c2a57f3e395b465f99915329741dba68,
title = "Drivers and barriers of vaccine acceptance among pregnant women in Kenya",
abstract = "Maternal vaccination coverage remains suboptimal globally and is lowest in low- and middle-income countries. Attitudes toward maternal vaccines have been characterized in middle-high income settings, however data from African countries are limited. We assessed drivers and barriers of vaccine acceptance among pregnant women in Kenya. We conducted a cross-sectional survey among pregnant women aged 15-49 y. We enrolled a convenience sample of women presenting for antenatal care at seven health-care facilities in four diverse counties (Nairobi, Mombasa, Marsabit, Siaya) of Kenya and from the community in two counties (Nairobi, Siaya). We described frequencies of socio-demographic characteristics of participants and their knowledge, attitudes, and beliefs regarding maternal vaccination. We enrolled 604 pregnant women with a median age of 26.5 y, of whom 48.2{\%} had primary education or less. More than 95{\%} agreed that maternal vaccines are {"}important for my health{"} and that getting vaccinated is {"}a good way to protect myself from disease{"}. The most commonly cited reason in favor of maternal vaccination was disease prevention (53.2{\%}). Fear of side effects to mother/baby (15.1{\%}) was the most frequently reported potential barrier. Influenza vaccine is not in routine use in Kenya; however, 77.8{\%} reported willingness to accept influenza vaccination during pregnancy. Maternal vaccination is well accepted among Kenyan pregnant women. We identified the provision of adequate vaccine information and addressing safety concerns as opportunities to improve maternal vaccine uptake. The expressed willingness to receive a vaccine not currently in routine use bodes well for implementation of new maternal vaccines in Kenya.",
author = "Otieno, {Nancy A} and Fredrick Otiato and Bryan Nyawanda and Maxwel Adero and Wairimu, {Winnie N} and Dominic Ouma and Raphael Atito and Andrew Wilson and Ines Gonzalez-Casanova and Malik, {Fauzia A} and Marc-Alain Widdowson and Omer, {Saad B} and Chaves, {Sandra S} and Verani, {Jennifer R}",
note = "CPDF",
year = "2020",
doi = "10.1080/21645515.2020.1723364",
language = "English",
pages = "1--9",
journal = "Human Vaccines & Immunotherapeutics",
issn = "2164-5515",
publisher = "Landes Bioscience",

}

RIS

TY - JOUR

T1 - Drivers and barriers of vaccine acceptance among pregnant women in Kenya

AU - Otieno, Nancy A

AU - Otiato, Fredrick

AU - Nyawanda, Bryan

AU - Adero, Maxwel

AU - Wairimu, Winnie N

AU - Ouma, Dominic

AU - Atito, Raphael

AU - Wilson, Andrew

AU - Gonzalez-Casanova, Ines

AU - Malik, Fauzia A

AU - Widdowson, Marc-Alain

AU - Omer, Saad B

AU - Chaves, Sandra S

AU - Verani, Jennifer R

N1 - CPDF

PY - 2020

Y1 - 2020

N2 - Maternal vaccination coverage remains suboptimal globally and is lowest in low- and middle-income countries. Attitudes toward maternal vaccines have been characterized in middle-high income settings, however data from African countries are limited. We assessed drivers and barriers of vaccine acceptance among pregnant women in Kenya. We conducted a cross-sectional survey among pregnant women aged 15-49 y. We enrolled a convenience sample of women presenting for antenatal care at seven health-care facilities in four diverse counties (Nairobi, Mombasa, Marsabit, Siaya) of Kenya and from the community in two counties (Nairobi, Siaya). We described frequencies of socio-demographic characteristics of participants and their knowledge, attitudes, and beliefs regarding maternal vaccination. We enrolled 604 pregnant women with a median age of 26.5 y, of whom 48.2% had primary education or less. More than 95% agreed that maternal vaccines are "important for my health" and that getting vaccinated is "a good way to protect myself from disease". The most commonly cited reason in favor of maternal vaccination was disease prevention (53.2%). Fear of side effects to mother/baby (15.1%) was the most frequently reported potential barrier. Influenza vaccine is not in routine use in Kenya; however, 77.8% reported willingness to accept influenza vaccination during pregnancy. Maternal vaccination is well accepted among Kenyan pregnant women. We identified the provision of adequate vaccine information and addressing safety concerns as opportunities to improve maternal vaccine uptake. The expressed willingness to receive a vaccine not currently in routine use bodes well for implementation of new maternal vaccines in Kenya.

AB - Maternal vaccination coverage remains suboptimal globally and is lowest in low- and middle-income countries. Attitudes toward maternal vaccines have been characterized in middle-high income settings, however data from African countries are limited. We assessed drivers and barriers of vaccine acceptance among pregnant women in Kenya. We conducted a cross-sectional survey among pregnant women aged 15-49 y. We enrolled a convenience sample of women presenting for antenatal care at seven health-care facilities in four diverse counties (Nairobi, Mombasa, Marsabit, Siaya) of Kenya and from the community in two counties (Nairobi, Siaya). We described frequencies of socio-demographic characteristics of participants and their knowledge, attitudes, and beliefs regarding maternal vaccination. We enrolled 604 pregnant women with a median age of 26.5 y, of whom 48.2% had primary education or less. More than 95% agreed that maternal vaccines are "important for my health" and that getting vaccinated is "a good way to protect myself from disease". The most commonly cited reason in favor of maternal vaccination was disease prevention (53.2%). Fear of side effects to mother/baby (15.1%) was the most frequently reported potential barrier. Influenza vaccine is not in routine use in Kenya; however, 77.8% reported willingness to accept influenza vaccination during pregnancy. Maternal vaccination is well accepted among Kenyan pregnant women. We identified the provision of adequate vaccine information and addressing safety concerns as opportunities to improve maternal vaccine uptake. The expressed willingness to receive a vaccine not currently in routine use bodes well for implementation of new maternal vaccines in Kenya.

U2 - 10.1080/21645515.2020.1723364

DO - 10.1080/21645515.2020.1723364

M3 - A1: Web of Science-article

C2 - 32208952

SP - 1

EP - 9

JO - Human Vaccines & Immunotherapeutics

JF - Human Vaccines & Immunotherapeutics

SN - 2164-5515

ER -

ID: 3376084